These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children. Pedersen FK; Henrichsen J; Schiffman G Acta Paediatr Scand; 1982 May; 71(3):451-5. PubMed ID: 7136661 [TBL] [Abstract][Full Text] [Related]
9. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. Baker CJ; Kasper DL; Edwards MS; Schiffman G N Engl J Med; 1980 Jul; 303(4):173-8. PubMed ID: 6155612 [TBL] [Abstract][Full Text] [Related]
10. Polyvalent pneumococcal polysaccharide vaccines. Hilleman MR; McLean AA; Vella PP; Weibel RE; Woodhour AF Bull World Health Organ; 1978; 56(3):371-5. PubMed ID: 28857 [TBL] [Abstract][Full Text] [Related]
11. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Hosea SW; Burch CG; Brown EJ; Berg RA; Frank MM Lancet; 1981 Apr; 1(8224):804-7. PubMed ID: 6111673 [TBL] [Abstract][Full Text] [Related]
12. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575 [TBL] [Abstract][Full Text] [Related]
13. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Hilleman MR; Carlson AJ; McLean AA; Vella PP; Weibel RE; Woodhour AF Rev Infect Dis; 1981; 3 Suppl():S31-42. PubMed ID: 7025159 [TBL] [Abstract][Full Text] [Related]
14. Pneumococcal antibody levels one decade after immunization of healthy adults. Mufson MA; Krause HE; Schiffman G; Hughey DF Am J Med Sci; 1987 May; 293(5):279-84. PubMed ID: 3591818 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Landesman SH; Schiffman G Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158 [TBL] [Abstract][Full Text] [Related]
16. Antibody response to pneumococcal vaccine in patients with solid tumors and lymphomas. Shildt RA; Boyd JF; McCracken JD; Schiffman G; Giolma JP Med Pediatr Oncol; 1983; 11(5):305-9. PubMed ID: 6633425 [TBL] [Abstract][Full Text] [Related]
17. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Sell SH; Wright PF; Vaughn WK; Thompson J; Schiffman G Rev Infect Dis; 1981; 3 Suppl():S97-107. PubMed ID: 7280450 [TBL] [Abstract][Full Text] [Related]
18. Immunization of patients with Sjögren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial. Karsh J; Pavlidis N; Schiffman G; Moutsopoulos HM Arthritis Rheum; 1980 Nov; 23(11):1294-8. PubMed ID: 7004446 [TBL] [Abstract][Full Text] [Related]
19. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report. Addiego JE; Ammann AJ; Schiffman G; Baehner R; Higgins G; Hammond D Lancet; 1980 Aug; 2(8192):450-2. PubMed ID: 6106099 [TBL] [Abstract][Full Text] [Related]
20. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. Robbins JB; Austrian R; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J; Mäkelä PH; Broome CV; Facklam RR; Tiesjema RH J Infect Dis; 1983 Dec; 148(6):1136-59. PubMed ID: 6361173 [No Abstract] [Full Text] [Related] [Next] [New Search]